Home >> Marketplace Archives >> MU School of Medicine, Roche team up

MU School of Medicine, Roche team up

Print Friendly, PDF & Email

September 2018—Roche announced the result of a collaboration with the University of Missouri School of Medicine to implement the company’s Navify tumor board solution, cloud-based clinical workflow and decision-support software to assist with cancer patient case reviews in tumor board and multidisciplinary team meetings.

The product supports care team collaboration and streamlines and standardizes clinical workflow by aggregating patient data from multiple sources, including medical histories, pathology reports, microscope slide and radiology images, and EMR notes, in one dashboard. The solution also allows experts in other locations to participate remotely in meetings.

MU Health Care has used the commercial version of the software with two of its nine oncology care teams and plans to implement the software across the remaining teams.

Roche, 317-521-2000


Check Also

Hemlibra for hemophilia A without FVIII inhibitors approved

Oct. 5, 2018—Roche announced the FDA’s approval of Hemlibra (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors.